These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 6976303)
1. Present status and future prospects for the hybridoma technology. Scharff MD; Roberts S In Vitro; 1981 Dec; 17(12):1072-7. PubMed ID: 6976303 [TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies in clinical immunology. Sevier ED; David GS; Martinis J; Desmond WJ; Bartholomew RM; Wang R Clin Chem; 1981 Nov; 27(11):1797-806. PubMed ID: 7028317 [TBL] [Abstract][Full Text] [Related]
3. Mapping of SJL/J reticulum cell sarcoma tumor-associated Ia antigens by T cell hybridomas: characterization of tumor-specific and shared epitopes detected on IE+ allogeneic cells. Ohnishi K; Bonavida B J Immunol; 1986 Jul; 137(2):733-40. PubMed ID: 2424977 [TBL] [Abstract][Full Text] [Related]
12. Antibody producing human-human hybridomas. II. Derivation and characterization of an antibody specific for human leukemia cells. Olsson L; Andreasen RB; Ost A; Christensen B; Biberfeld P J Exp Med; 1984 Feb; 159(2):537-50. PubMed ID: 6582214 [TBL] [Abstract][Full Text] [Related]
13. High-resolution analysis of the B cell repertoire before and after polyethylene glycol fusion reveals preferential fusion of rare antigen-specific B cells. Dubois AR; Buerckert JP; Sinner R; Faison WJ; Molitor AM; Muller CP Hum Antibodies; 2016 Jun; 24(1-2):1-15. PubMed ID: 27472868 [TBL] [Abstract][Full Text] [Related]
14. Bispecific monoclonal antibodies directed to CD16 and to a tumor-associated antigen induce target-cell lysis by resting NK cells and by a subset of NK clones. Ferrini S; Prigione I; Miotti S; Ciccone E; Cantoni C; Chen Q; Colnaghi MI; Moretta L Int J Cancer; 1991 May; 48(2):227-33. PubMed ID: 1826900 [TBL] [Abstract][Full Text] [Related]
15. Production of T-T hybrids from T cell clones. Direct comparison between cloned T cells and T hybridoma cells derived from them. Ozaki S; Durum SK; Muegge K; York-Jolley J; Berzofsky JA J Immunol; 1988 Jul; 141(1):71-8. PubMed ID: 2454265 [TBL] [Abstract][Full Text] [Related]
17. The use of hybrid hybridomas to target human cytotoxic T lymphocytes. Lanzavecchia A; Scheidegger D Eur J Immunol; 1987 Jan; 17(1):105-11. PubMed ID: 3102250 [TBL] [Abstract][Full Text] [Related]
18. Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies. Haynesworth SE; Baber MA; Caplan AI Bone; 1992; 13(1):69-80. PubMed ID: 1316137 [TBL] [Abstract][Full Text] [Related]
19. Hybridoma technologies for antibody production. Tomita M; Tsumoto K Immunotherapy; 2011 Mar; 3(3):371-80. PubMed ID: 21395379 [TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibodies for diagnostic tests and affinity chromatography: a first step to antibody engineering. Schönherr OT; Roelofs H Dev Biol Stand; 1981; 50():235-42. PubMed ID: 7341293 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]